论文部分内容阅读
目的:探讨小儿病毒性脑膜炎的临床治疗方法。方法:选择2009年1月~2013年1月期间我院接收并确诊为小儿病毒性脑膜炎的患儿72例,将其随机分为治疗组和对照组,各36例。对照组患儿采取常规治疗,治疗组患儿在常规治疗基础上增加静脉注射丙种球蛋白,比较两组患儿临床疗效。结果:两组患者共72例均治疗后痊愈,治愈率100%。但观察组患儿的退热时间、惊厥持续时间及住院时间相比对照组时间明显缩短比较差异具有统计学意义(P<0.05)。结论:对病毒性脑膜炎患儿在常规治疗基础上静脉注射丙种球蛋白(IVIG),可以有效安全、明显缩短病程,促进患儿早日痊愈。
Objective: To investigate the clinical treatment of viral meningitis in children. Methods: From January 2009 to January 2013, 72 children with viral meningitis in our hospital were selected and randomly divided into treatment group and control group, 36 cases each. Children in the control group were treated routinely. The children in the treatment group received intravenous gamma globulin supplementation on the basis of routine treatment. The clinical efficacy of the two groups was compared. Results: A total of 72 patients in both groups recovered after treatment, the cure rate was 100%. However, the observation group of children with antipyretic time, duration of convulsions and hospitalization compared with the control group was significantly shorter time difference was statistically significant (P <0.05). Conclusion: IVIG can be effectively and safely administered to children with viral meningitis on the basis of routine treatment, which significantly shortens the course of the disease and promotes the early recovery of the child.